165
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Analysis of Race and Gender Disparities in Incidence-Based Mortality in Patients Diagnosed with Thyroid Cancer from 2000 to 2016

ORCID Icon, , ORCID Icon &
Pages 1589-1594 | Published online: 16 Dec 2020

References

  • Morris LG, Tuttle RM, Davies L. Changing trends in the incidence of thyroid cancer in the United States. JAMA Otolaryngol Head Neck Surgery. 2016;142(7):709–711. doi:10.1001/jamaoto.2016.0230
  • Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA. 2017;317(13):1338–1348. doi:10.1001/jama.2017.271928362912
  • Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surgery. 2014;140(4):317–322. doi:10.1001/jamaoto.2014.1
  • La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136(9):2187–2195. doi:10.1002/ijc.2925125284703
  • Sosa JA, Hanna JW, Robinson KA, Lanman RB. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;154(6):1420–1427. doi:10.1016/j.surg.2013.07.00624094448
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.31912902
  • Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–2167. doi:10.1001/jama.295.18.216416684987
  • Yan KL, Li S, Tseng C-H, et al. Rising incidence and incidence-based mortality of thyroid cancer in California, 2000–2017. J Clin Endocrinol Metab. 2020;105(6):dgaa121. doi:10.1210/clinem/dgaa12132166320
  • Carling T, Ocal IT, Udelsman R. Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg. 2007;31(5):916–923. doi:10.1007/s00268-006-0837-317345120
  • Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surgery. 1992;164(6):658–661. doi:10.1016/S0002-9610(05)80729-9
  • Schlumberger MJ. Papillary and follicular thyroid carcinoma. New England J Med. 1998;338(5):297–306. doi:10.1056/NEJM1998012933805069445411
  • Sherma SI. Thyroid carcinoma. Lancet. 2003;361(9356):501–511. doi:10.1016/S0140-6736(03)12488-912583960
  • O’Neill JP, Shaha AR. Anaplastic thyroid cancer. Oral Oncol. 2013;49(7):702–706. doi:10.1016/j.oraloncology.2013.03.44023583302
  • Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006. Thyroid. 2011;21(2):125–134. doi:10.1089/thy.2010.002121186939
  • Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol. 2010;6(11):1771–1779. doi:10.2217/fon.10.12721142662
  • Yao R, Chiu CG, Strugnell SS, Gill S, Wiseman SM. Gender differences in thyroid cancer: a critical review. Expert Rev Endocrinol Metab. 2011;6(2):215–243. doi:10.1586/eem.11.930290447
  • Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: A population‐based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973–1991. Cancer. 1997;79(3):564–573. doi:10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-09028369
  • Kilfoy BA, Devesa SS, Ward MH, et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Prevention Biomarkers. 2009;18(4):1092–1100. doi:10.1158/1055-9965.EPI-08-0976
  • Jonklaas J, Nogueras-Gonzalez G, Munsell M, et al. The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab. 2012;97(6):E878–E887.22496497
  • Machens A, Hauptmann S, Dralle H. Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Clin Endocrinol. 2006;65(4):500–505. doi:10.1111/j.1365-2265.2006.02623.x
  • Micheli A, Ciampichini R, Oberaigner W, et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer. 2009;45(6):1017–1027. doi:10.1016/j.ejca.2008.11.00819109009
  • Chu KC, Miller BA, Feuer EJ, Hankey BF. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol. 1994;47(12):1451–1461. doi:10.1016/0895-4356(94)90089-27730854
  • Saad AM, Gad MM, Al-Husseini MJ, Ruhban IA, Sonbol MB, Ho TH. Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-based study. Clin Genitourin Cancer. 2019;17(1):46–57. e45. doi:10.1016/j.clgc.2018.10.00230391138
  • Janz TA, Neskey DM, Nguyen SA, Lentsch EJ. Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study. World j Otorhinolaryngol Head Neck Surgery. 2019;5(1):34–40. doi:10.1016/j.wjorl.2018.05.006
  • Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma: treatment outcome and prognostic factors. Cancer. 2005;103(7):1330–1335. doi:10.1002/cncr.2093615739211
  • Ranganath R, Shah MA, Shah AR. Anaplastic thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2015;22(5):387–391. doi:10.1097/MED.000000000000018926313900
  • Smallridge RC, Copland J. Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol. 2010;22(6):486–497. doi:10.1016/j.clon.2010.03.013
  • Soheylizad M, Khazaei S, Jenabi E, Delpisheh A, Veisani Y. The relationship between human development index and its components with thyroid cancer incidence and mortality: using the decomposition approach. Int J Endocrinol Metabolism. 2018;16:4.
  • Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013.
  • Siironen P, Louhimo J, Nordling S, et al. Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumor Biol. 2005;26(2):57–64. doi:10.1159/000085586
  • Lamartina L, Grani G, Durante C, Filetti S. Recent advances in managing differentiated thyroid cancer. F1000Research. 2018;7.29527296
  • Nash SH, Lanier AP, Southworth MB. Occurrence of endocrine and thyroid cancers among alaska native people, 1969–2013. Thyroid. 2018;28(4):481–487. doi:10.1089/thy.2017.040829439613
  • Liddell JL, Burnette CE, Roh S, Lee Y-S. Healthcare barriers and supports for American Indian women with cancer. Soc Work Health Care. 2018;57(8):656–673. doi:10.1080/00981389.2018.147483729775173
  • Moo-Young TA, Panergo J, Wang CE, et al. Variations in clinicopathologic characteristics of thyroid cancer among racial ethnic groups: analysis of a large public city hospital and the SEER database. Am J Surgery. 2013;206(5):632–640. doi:10.1016/j.amjsurg.2013.07.015
  • Nguyen MLT, Hu J, Hastings KG, et al. Thyroid cancer mortality is higher in Filipinos in the United States: an analysis using national mortality records from 2003 through 2012. Cancer. 2017;123(24):4860–4867. doi:10.1002/cncr.3095828881423
  • Kus LH, Shah M, Eski S, Walfish PG, Freeman JL. Thyroid cancer outcomes in Filipino patients. Archives Otolaryngol Head Neck Surgery. 2010;136(2):138–142. doi:10.1001/archoto.2009.206